๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase 2 trial of concurrent bevacizumab and transhepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma

โœ Scribed by Buijs, Manon; Reyes, Diane K.; Pawlik, Timothy M.; Blackford, Amanda L.; Salem, Riad; Messersmith, Wells A.; Weekes, Colin D.; Mulcahy, Mary; Kamel, Ihab R.; Geschwind, Jean-Francois H.


Book ID
120935994
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
237 KB
Volume
119
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Evaluation of responses to chemoemboliza
โœ Osama M. Ebied; Michael P. Federle; Brian I. Carr; Karen M. Pealer; Wei Li; Nikh ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 280 KB ๐Ÿ‘ 2 views

## Abstract ## BACKGROUND The authors used computed tomography (CT) scans to correlate the changes in tumor vascularity, necrosis, and size with response and survival after transcatheter arterial chemoembolization (TACE) in patients with advanced, unresectable, hepatocellular carcinoma (HCC). ##